SeaBeLife SAS

https://www.seabelife.com

SeaBeLife is a biotechnology company specialized in the development of drug candidates that block cellular necrosis in order to protect or regenerate organs affected by severe pathologies – for which there are no alternative, effective treatments. The company primarily targets acute pathologies of the liver and kidneys, whilst leading other research activities in ocular and degenerative conditions. SeaBeLife’s technology centers around a portfolio of more than 45 biologically-active relevant molecules, which have the unique characteristic of inhibiting two forms of regulated and programmed cell death – necroptosis and ferroptosis – in pathological conditions. The company has filed four patents to protect the applications of these molecules. It has already demonstrated in vivo proof of concept for a first molecule in four indications and has started preclinical development in acute liver and kidney pathologies. SeaBeLife also obtained promising preliminary results with two other molecules in in vitro and in vivo models for chronic pathologies. Founded in March 2019 and based in Brittany, France, SeaBeLife is led by CEO and co-founder Morgane Rousselot, who holds a PhD in biochemistry. The company is based on the research works of Stéphane Bach, PhD, CNRS research engineer, Marie-Thérèse Dimanche-Boitrel, research director at IRSET (the French institute for research in environmental and occupational health) and Claire Delehouzé, a biotechnology engineer, co-founder and CTO at SeaBeLife. SeaBeLife currently employs six people and has raised €3.9 million ($4.3M) in private equity and grants since its creation. *

	Start	2019-03-28 established
	Industry	drug development
	Industry 2	pharmaceutical
	Person	Rousselot, Morgane (SeaBeLife 202203 CEO + Co-Founder)
	Person 2	Avenard, Gilles (Acticor Biotech 201612 CEO)

	Region	Bretagne (Britanny) (region)
	Country	France
	Street	place Georges Teissier
	City	29680 Roscoff
	Tel	+33-2-9829-2348
		Address record changed: 2022-03-19

Basic data	Employees	A: 1 to 10 (2022-03-14)

		* Document for »About Section«: SeaBeLife SAS. (3/14/22). "Press Release: SeaBeLife Receives Close to €1.4M Deep Tech Financing from Bpifrance". Roscoff.

		Record changed: 2024-03-30